Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons
Launched by UNIVERSITY HOSPITAL BISPEBJERG AND FREDERIKSBERG · Nov 15, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new ultrasound technique called Super Resolution ultrasound imaging of Erythrocytes (SURE) to better understand small blood vessels in tendons, particularly in people with tendon injuries known as tendinopathy. The researchers want to find out if this method can accurately detect tiny blood vessels, gather important information about blood flow, and tell the difference between blood flow in injured tendons compared to healthy ones.
To join the study, participants should be between 18 and 70 years old, have a body mass index (BMI) below 30, and be able to lie still for about a minute. Unfortunately, those who are pregnant, smoke, have diabetes, or have had other significant injuries to the tendon cannot participate. Participants will receive a non-invasive ultrasound examination of either their Achilles tendon (near the heel) or patellar tendon (near the knee) using a special high-frequency ultrasound machine. This research could help improve diagnosis and treatment options for tendon injuries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 to 70 years of age.
- • BMI below 30.
- • Able to lie still for 1 minute.
- • Capable of providing signed informed consent.
- Exclusion Criteria:
- • Pregnancy.
- • Dementia.
- • Smoking.
- • Diabetes.
- • Arthritis.
- • Current or historical injuries to the tendon or surrounding tissue aside from tendinopathy.
- • Medical or surgical treatments for their tendinopathy that may influence blood flow.
About University Hospital Bispebjerg And Frederiksberg
University Hospital Bispebjerg and Frederiksberg is a leading academic medical institution in Denmark, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge scientific inquiry with patient-centered care, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. The institution emphasizes a strong commitment to ethical standards and regulatory compliance, ensuring that all trials are designed to enhance medical knowledge and improve patient outcomes. With a focus on a wide range of therapeutic areas, University Hospital Bispebjerg and Frederiksberg strives to contribute significantly to the global medical community and the advancement of evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Trial Officials
Michael Kjaer, PhD
Study Director
University Hospital Bispebjerg and Frederiksberg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported